Cannabinoid hyperemesis syndrome is increasingly important as cannabis use grows and THC potency rises
A Federal Practitioner review highlighted that converging factors of cannabis legalization, increasing use, and rising THC potency make cannabinoid hyperemesis syndrome an increasingly important condition for clinicians to recognize.
Quick Facts
What This Study Found
The review from a federal healthcare publication emphasized that cannabinoid hyperemesis syndrome (CHS) sits at the intersection of three converging trends: legislative efforts expanding cannabis access, increasing prevalence of cannabis use, and rising THC potency. These factors combine to make CHS a more commonly encountered but still frequently missed diagnosis.
Key Numbers
The review highlights three converging factors: legislative changes, increasing prevalence, and THC toxicity.
How They Did This
Clinical review article published in a federal healthcare practitioner journal aimed at VA, DoD, and PHS healthcare professionals.
Why This Research Matters
CHS is often misdiagnosed or unrecognized, leading to repeated ER visits, unnecessary testing, and delayed treatment. Healthcare providers in federal settings (VA, military, public health) need awareness as cannabis use patterns evolve among their patient populations.
The Bigger Picture
The publication venue, Federal Practitioner (serving VA, DoD, and PHS), is notable. Federal healthcare systems serve populations with distinct cannabis use patterns, and clinician education in these settings is essential for recognizing CHS.
What This Study Doesn't Tell Us
Brief overview article with a very concise abstract. Limited detail on specific clinical recommendations or evidence base.
Questions This Raises
- ?How common is CHS in federal healthcare patient populations?
- ?Are VA and military healthcare providers adequately trained to recognize CHS?
- ?Does the federal scheduling of cannabis affect CHS reporting and diagnosis?
Trust & Context
- Key Stat:
- Converging factors: legalization + increased use + higher THC potency = more CHS cases
- Evidence Grade:
- Brief clinical overview. Provides awareness but limited detailed evidence review.
- Study Age:
- Published in 2017. CHS awareness in clinical practice has continued to improve.
- Original Title:
- Cannabinoid Hyperemesis Syndrome.
- Published In:
- Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 34(10), 33-36 (2017)
- Authors:
- Fleming, J Eric, Lockwood, Sean
- Database ID:
- RTHC-01380
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is cannabinoid hyperemesis syndrome?
CHS is a condition where chronic cannabis users develop recurrent episodes of severe nausea, vomiting, and abdominal pain. It is paradoxical because cannabis is often used to treat nausea. Symptoms resolve completely when cannabis use stops.
Why is CHS becoming more common?
Three factors are converging: more states legalizing cannabis, more people using it, and cannabis products becoming more potent (higher THC). Higher THC exposure may increase the likelihood of developing CHS.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- THC-potency-increase-over-time
- cannabis-harm-reduction-opioids-alcohol-replacement
- cannabis-legalization-effects-health-data
- cannabis-relapse-cycle-pattern
- cannabis-tolerance-break-guide
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-cut-back-on-weed-moderation
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- microdosing-cannabis-benefits
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- safer-cannabis-use-guidelines
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- sober-october-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- tolerance-break-weed
- weed-for-opioid-withdrawal
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-01380APA
Fleming, J Eric; Lockwood, Sean. (2017). Cannabinoid Hyperemesis Syndrome.. Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 34(10), 33-36.
MLA
Fleming, J Eric, et al. "Cannabinoid Hyperemesis Syndrome.." Federal practitioner : for the health care professionals of the VA, 2017.
RethinkTHC
RethinkTHC Research Database. "Cannabinoid Hyperemesis Syndrome." RTHC-01380. Retrieved from https://rethinkthc.com/research/fleming-2017-cannabinoid-hyperemesis-syndrome
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.